The Effect That Angiostatin Inhibits Growth of Transplanted Tumor of Oral Squamous-Cell Carcinoma

蒋立辉,刘志刚,向蓉,陈芳育

DOI: https://doi.org/10.3969/j.issn.1009-5519.2007.15.001

2007-01-01

Abstract:Objective:(1)To construct the model of transplanted tumor of oral squamous-cell carcinoma.(2)To study the effect that angiostatin inhibits growth of transplanted tumor of oral squamous-cell carcinoma.Methods:To construct the models of transplanted tumor of oral squamous-cell carcinoma.Tca8113 cells were cultivated and inoculated to twenty nude mice.A week later, the models of transplanted tumor of oral squamous-cell carcinoma were constructed.The twenty nude mice were divided into 4 groups,ie one control group and 3 treatment groups.The treatment groups bearing human Tca8113 were subcutaneously injected with different dose of rhAGN daily for 35 days,the size of tumor was measured every week .At the end of the treatment,all the speciment were dissected and weighed. The volume and weight of tumor were analyzed by statistics.Results:The volume of tumor was(4945±364)mm3,(2423±258)mm3 and(472±48)mm3 at rhAGN dose of 50 mg/(kg·d),100 mg/(kg·d)and 200 mg/(kg·d) respectively;Compared with the control group,the volume and weight of tumor were significantly decreased(P0.05,P0.01),and the inhibitory rate of growth on transplanted tumors of oral squamous-cell carcinoma was 31.5%,62.0% and 85.5% respectively.Conclusion:The angiostatin can significantly inhibit growth of human oral squamous-cell carcinoma in vivo in a dose-dependent manner.